Skip to content
naulon
Not checkedNot checked for notices yet.

How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and “tomorrow” [version 1; referees: 2 approved]

Leif D. Nelin, Vineet Bhandari

F1000Research · 2017

doi:10.12688/f1000research.10832.1 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Bronchopulmonary dysplasia, or BPD, is the most common chronic lung disease in infants. Genetic predisposition and developmental vulnerability secondary to antenatal and postnatal infections, compounded with exposure to hyperoxia and invasive mechanical ventilation to an immature lung, result in persistent inflammation, culminating in the characteristic pulmonary phenotype of BPD of impaired alveolarization and dysregulated vascularization. In this article, we highlight specific areas in current management, and speculate on therapeutic strategies that are on the horizon, that we believe will make an impact in decreasing the incidence of BPD in your neonatal intensive care units.

Abstract licence: CC BY

References63

  1. 39.

39 more references, whose wording the paper’s licence keeps private.

All 63 references

Cited by papers we hold1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.